Boxer Capital’s Mirum Pharmaceuticals MIRM Stock Holding History

Boxer Capital’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-317,000	Closed	-$5.48M	–	96
2021 Q2	$5.48M	Hold	317,000	–	–	0.19%	75
2021 Q1	$6.28M	Hold	317,000	–	–	0.21%	66
2020 Q4	$5.54M	Hold	317,000	–	–	0.18%	65
2020 Q3	$6.11M	Hold	317,000	–	–	0.21%	64
2020 Q2	$6.17M	Hold	317,000	–	–	0.27%	53
2020 Q1	$4.44M	Hold	317,000	–	–	0.3%	50
2019 Q4	$7.77M	Buy	+317,000	New	+$3.38M	0.44%	42

Other funds holding MIRM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital's MIRM Position: Q3 2021 in Review

Boxer Capital sold out of Mirum Pharmaceuticals (MIRM) in Q3 2021, closing a stake of 317,000 shares — an estimated $5.48M sold.

Boxer Capital first reported a position in MIRM in Q4 2019 and held it in 7 quarters. The position peaked at $7.77M in Q4 2019. 73 funds tracked by Wall St. Rank hold MIRM as of Q3 2021.

Boxer Capital reported no remaining Mirum Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Boxer Capital sold 317,000 Mirum Pharmaceuticals shares in Q3 2021, an estimated $5.48M.
Boxer Capital first reported a position in Mirum Pharmaceuticals in Q4 2019 and held it in 7 quarters.
Boxer Capital's Mirum Pharmaceuticals position peaked at $7.77M in Q4 2019.
73 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2021.

Based on Boxer Capital's 13F filing for Q3 2021, filed 15 Nov 2021.